Tackling HLA Deficiencies Head on with Oncolytic Viruses

SIMPLE SUMMARY: Oncolytic viruses show great promise as anticancer agents by simultaneously lysing cancer cells while stimulating innate and adaptive immune responses. However, the extent to which the adaptive immune system contributes to overall efficacy alongside oncolytic viruses is, in part, dep...

Descripción completa

Detalles Bibliográficos
Autores principales: Fisher, Kerry, Hazini, Ahmet, Seymour, Leonard W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916504/
https://www.ncbi.nlm.nih.gov/pubmed/33578735
http://dx.doi.org/10.3390/cancers13040719

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7916504/
https://www.ncbi.nlm.nih.gov/pubmed/33578735
http://dx.doi.org/10.3390/cancers13040719

Ejemplares similares